Drug package

Information

  • Patent Grant
  • D877625
  • Patent Number
    D877,625
  • Date Filed
    Tuesday, May 30, 2017
    7 years ago
  • Date Issued
    Tuesday, March 10, 2020
    4 years ago
  • Inventors
    • LoPrete; Jeffrey (Cranbury, NJ, US)
    • Mustufa; Muzammil (Cranbury, NJ, US)
    • Gershkowitz; Jayne (Cranbury, NJ, US)
  • Original Assignees
  • Examiners
    • Koenig; Vy N
    Agents
    • Servilla Whitney LLC
  • US Classifications
    Field of Search
    • US
    • D09 414-423
    • D09 430-434
    • D09 456-457
    • D09 711
    • D09 713
    • D09 721-722
    • D24 100-104
    • CPC
    • B65D5/00
    • B65D5/02
    • B65D5/18
    • B65D5/20
  • International Classifications
    • 0901
    • Term of Grant
      15Years
      Disclaimer
      This patent is subject to a terminal disclaimer.
Abstract
Description


FIG. 1 is a front top right perspective view of a drug package showing our new design;



FIG. 2 is a back top left perspective view thereof;



FIG. 3 is a top view thereof;



FIG. 4 is a bottom view thereof;



FIG. 5 is a front view thereof;



FIG. 6 is a back view thereof;



FIG. 7 is a right view thereof; and,



FIG. 8 is a left view thereof.


The broken lines depict environmental subject matter only and form no part of the claimed design.


Claims
  • The ornamental design for a drug package, substantially as shown and described.
US Referenced Citations (29)
Number Name Date Kind
D263559 Poore Mar 1982 S
D320930 Richards Oct 1991 S
D339742 Walchek, Jr. Sep 1993 S
D441192 Park May 2001 S
D455958 Burrus Apr 2002 S
D478810 Wilson Aug 2003 S
D505320 Gattefosse May 2005 S
D511465 Smith Nov 2005 S
D513981 Gibbs Jan 2006 S
D521862 Siethoff May 2006 S
D528013 Hines Sep 2006 S
D539166 Spencer Mar 2007 S
D540665 Gupta Apr 2007 S
D546198 Currie Jul 2007 S
D553494 Dehlin Oct 2007 S
D562153 Ruble Feb 2008 S
D592047 Glass May 2009 S
D599654 Kosaka Sep 2009 S
D622158 Proulx Aug 2010 S
D658069 Boyer Apr 2012 S
D702116 Buchanan Apr 2014 S
D715634 Stevens Oct 2014 S
D723390 Eriksson Mar 2015 S
D748978 Glass Feb 2016 S
D770303 Gelbaum Nov 2016 S
D789196 Waters Jun 2017 S
D795083 Safiullin Aug 2017 S
D806570 Gelbaum Jan 2018 S
D828767 von Badinski Sep 2018 S
Foreign Referenced Citations (1)
Number Date Country
2015164210 Oct 2015 WO
Non-Patent Literature Citations (6)
Entry
MWV introduces Shellpak Renew with Optilock. [online] Published on Dec. 23, 2014. Retrieved Mar. 8, 2018 from URL: https://www.businesswire.eom/news/home/20130808005877/en/MWV-introduces-Shellpak%C2%AE-Renew-Optilock%E2%84%A2-technology-smallest.
“Amicus Therapeutics Announces European Commission Approval for Galafold™ (Migalastat) in Patients with Fabry Disease in European Union”, Amicus Therapeutics Press Release, May 31, 2016, 3 pages.
File History for U.S. Appl. No. 29/585,388, 108 pages.
Galafold 123 mg Packaging in German, May 30, 2016, 2 pages.
Galafold Product Information, May 30, 2016, 45 pages.
NDA 208623 Accelerated Approval Letter and Labeling, Aug. 10, 2018, 40 pages.